The Cochlear Ltd (ASX: COH) share price is down 14% after reporting its FY26 first-half result with major profit growth.

Cochlear is a hearing device business globally which provides both implants and services.

Cochlear FY26 first half result

Here are some of the highlights of the result for the six months to 31 December 2025:

What happened during this period?

The business reported that the number of Cochlear implant units increased by 6% to 27,016.

Within the total sales revenue growth of 1%, cochlear implants revenue decreased slightly to $724 million, services (sound processor upgrades and other) sales revenue grew 2% to $311.6 million and acoustics revenue was flat at $140.4 million.

Across developed markets, the focus has…